Private Equity

After a $6M cash infusion and leadership change, the diagnostics firm is selling its flagship product to chase a high-risk, high-reward U.S. market.

Profitable and with little debt, this holding company is leveraging a diverse portfolio as it prepares for a major stock market uplist. Here's a closer look.

With 23,000 metres of drilling, Copper Giant aims to unlock one of the world's largest undeveloped copper caches, vital for the energy transition.

Fresh off a $1.1B IPO and a #1 GreenTech ranking, BETA Technologies faces investors to prove its electric aviation vision is commercially viable.

Real estate giant Kennedy Wilson agrees to an all-cash acquisition by its CEO and Fairfax Financial, offering a 46% premium to go private.

Warner Bros. Discovery pushes for a Netflix merger but opens a one-week window for Paramount Skydance to fix its flawed bid. A bidding war looms.

Backed by Bessemer Investors, Tencarva Machinery continues its strategic expansion, acquiring a niche expert to solidify its dominance in the Ohio Valley.

With a key depression drug nearing Phase 3 and more data imminent, AtaiBeckley is set to make its case to Wall Street at three major March conferences.

With all regulatory hurdles cleared, GDI makes a final push for shareholder approval on a $36.60 per share buyout from private equity firm Birch Hill.

The world's largest bedding company raises its dividend for the sixth time in five years, flexing financial muscle despite mixed signals from Wall Street.

Brunswick Exploration launches a new drill program at a major Quebec lithium find, part of a global strategy in a surging market for critical minerals.

Allocate's 350% asset growth signals a major shift as wealth advisors embrace private markets. Discover how its AI-powered platform is making it possible.

BC Ferries' fleet renewal advances with MacGregor tech for four hybrid ships, promising greener voyages, higher capacity, and enhanced reliability for BC.

Nawal Ouzren steps down as CEO for personal reasons just after a €60M financing. Chairman Amit Munshi takes over as the biotech faces key milestones.

Strategic operator Exa Capital acquires clinical workforce leader StaffReady, betting its 'forever' investment model can boost healthcare efficiency.

Greece signs a landmark deal with Chevron and HELLENiQ for deep-sea hydrocarbon exploration, seeking energy independence amid high environmental stakes.

With a novel glutamate-targeting drug and a €38M cash injection, Newron aims to transform care for treatment-resistant schizophrenia.

The deal, backed by private equity, aims to streamline complex Medicaid billing, impacting both hospital finances and patient access to care.

Despite public speculation, a new survey shows Capitol Hill aides, especially Republicans, are deeply skeptical of a Trump 2028 bid, citing constitutional barriers.

The major CRO acquisition deepens Worldwide's oncology and FSP capabilities, signaling a strategic move in the consolidating clinical research market.